![Michel Kaczorek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michel Kaczorek joined Synt:em SA in 1995 and currently serves as President.
He is a Director of CliniGenetics SA.
Aktiva positioner av Michel Kaczorek
| Företag | Position | Start |
|---|---|---|
Synt:em SA
 Synt:em SA Pharmaceuticals: MajorHealth Technology Researches and manufactures drugs for the treatment of pain and cancer | Verkställande Direktör | 1995-01-01 |
Tidigare kända positioner av Michel Kaczorek
| Företag | Position | Slut |
|---|---|---|
CliniGenetics SA
 CliniGenetics SA Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases | Direktör/Styrelseledamot | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
2
Första gradens relationer
2
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 2 |
|---|---|
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Researches and manufactures drugs for the treatment of pain and cancer | Health Technology |
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
